Then, we constructed MICAL2 knockdown shRNA and TGFRI knockdown shRNA and evaluated their effects on the ability of glioma cells to invade and migrate in U87 and U251 cell lines. The gene discussed is MICAL2; the disease is central nervous system cancer.